{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T23:47:33Z","timestamp":1782085653537,"version":"3.54.5"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T00:00:00Z","timestamp":1776902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"vor","delay-in-days":60,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Hospital Fund of the Second Affiliated Hospital of Xi\u2019an Jiaotong University","award":["No. YJ(QN)202328"],"award-info":[{"award-number":["No. YJ(QN)202328"]}]},{"name":"Shaanxi Cancer Hospital National Natural Science Foundation Incubation Project","award":["SCB2417"],"award-info":[{"award-number":["SCB2417"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-026-02151-1","type":"journal-article","created":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T16:03:51Z","timestamp":1776960231000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The SUMO specific peptidase SENP3 promotes papillary thyroid cancer progression by deSUMOylation of SETDB1 and regulating GLI2 transcription"],"prefix":"10.1007","volume":"26","author":[{"given":"Zhe","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ze","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dengfeng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,23]]},"reference":[{"key":"2151_CR1","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1055\/a-1089-7870","volume":"52","author":"KA Araque","year":"2020","unstructured":"Araque KA, Gubbi S, Klubo-Gwiezdzinska J. Updates on the management of thyroid cancer. Hormone metabolic Res = Hormon- und Stoffwechselforschung = Horm et Metab. 2020;52:562\u201377.","journal-title":"Hormone metabolic Res = Hormon- und Stoffwechselforschung = Horm et Metab"},{"key":"2151_CR2","doi-asserted-by":"publisher","first-page":"450","DOI":"10.7150\/ijms.29935","volume":"16","author":"MI Abdullah","year":"2019","unstructured":"Abdullah MI, Junit SM, Ng KL, Jayapalan JJ, Karikalan B, Hashim OH. Papillary thyroid cancer: genetic alterations and molecular biomarker investigations. Int J Med Sci. 2019;16:450\u201360.","journal-title":"Int J Med Sci"},{"key":"2151_CR3","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.tibs.2020.09.002","volume":"46","author":"NS Jansen","year":"2021","unstructured":"Jansen NS, Vertegaal ACO. A chain of events: regulating target proteins by SUMO polymers. Trends Biochem Sci. 2021;46:113\u201323.","journal-title":"Trends Biochem Sci"},{"key":"2151_CR4","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1152\/physrev.00025.2019","volume":"100","author":"HM Chang","year":"2020","unstructured":"Chang HM, Yeh ETH. From bench to bedside. Physiol Rev. 2020;100:1599\u2013619.","journal-title":"Physiol Rev"},{"key":"2151_CR5","first-page":"997","volume":"71","author":"P Bialik","year":"2017","unstructured":"Bialik P, Wo\u017aniak K. Sumo proteases as potential targets for cancer therapy. Postepy Hig Med Dosw(Online). 2017;71:997\u20131004.","journal-title":"Postepy Hig Med Dosw(Online)"},{"key":"2151_CR6","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.csbj.2015.03.001","volume":"13","author":"A Kumar","year":"2015","unstructured":"Kumar A, Zhang KY. Advances in the development of SUMO specific protease (SENP) inhibitors. Comput Struct Biotechnol J. 2015;13:204\u201311.","journal-title":"Comput Struct Biotechnol J"},{"key":"2151_CR7","doi-asserted-by":"crossref","unstructured":"Kunz K, Piller T, M\u00fcller S. SUMO-specific proteases and isopeptidases of the SENP family at a glance. J Cell Sci, 131 (2018).","DOI":"10.1242\/jcs.211904"},{"key":"2151_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.786136","volume":"8","author":"PW Hotz","year":"2021","unstructured":"Hotz PW, M\u00fcller S, Mendler L. Sumo-specific isopeptidases tuning cardiac sumoylation in health and disease. Front Mol Biosci. 2021;8:786136.","journal-title":"Front Mol Biosci"},{"key":"2151_CR9","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1016\/j.celrep.2020.01.036","volume":"30","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Yang K, Yang J, Lao Y, Deng L, Deng G, et al. SENP3 suppresses osteoclastogenesis by de-conjugating SUMO2\/3 from IRF8 in bone marrow-derived monocytes. Cell Rep. 2020;30:1951-1963.e1954.","journal-title":"Cell Rep"},{"key":"2151_CR10","doi-asserted-by":"publisher","first-page":"5826","DOI":"10.1038\/onc.2016.124","volume":"35","author":"Z Zhou","year":"2016","unstructured":"Zhou Z, Wang M, Li J, Xiao M, Chin YE, Cheng J, et al. Sumoylation and SENP3 regulate STAT3 activation in head and neck cancer. Oncogene. 2016;35:5826\u201338.","journal-title":"Oncogene"},{"key":"2151_CR11","doi-asserted-by":"publisher","DOI":"10.1177\/1533033820956988","volume":"19","author":"P Yang","year":"2020","unstructured":"Yang P, Liu Y, Qi YC, Lian ZH. High SENP3 expression promotes cell migration, invasion, and proliferation by modulating DNA methylation of E-cadherin in osteosarcoma. Technology in cancer research & treatment. 2020;19:1533033820956988.","journal-title":"Technology in cancer research & treatment"},{"key":"2151_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/v12060596","author":"K Fukuda","year":"2020","unstructured":"Fukuda K, Shinkai Y. SETDB1-mediated silencing of retroelements. Viruses. 2020. https:\/\/doi.org\/10.3390\/v12060596.","journal-title":"Viruses"},{"key":"2151_CR13","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1080\/14728222.2017.1279604","volume":"21","author":"AV Karanth","year":"2017","unstructured":"Karanth AV, Maniswami RR, Prashanth S, Govindaraj H, Padmavathy R, Jegatheesan SK, et al. Emerging role of Setdb1 as a therapeutic target. Expert Opin Ther Targets. 2017;21:319\u201331.","journal-title":"Expert Opin Ther Targets"},{"key":"2151_CR14","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1158\/0008-5472.CAN-20-2906","volume":"81","author":"D Strepkos","year":"2021","unstructured":"Strepkos D, Markouli M, Klonou A, Papavassiliou AG, Piperi C. Histone methyltransferase SETDB1: a common denominator of tumorigenesis with therapeutic potential. Cancer Res. 2021;81:525\u201334.","journal-title":"Cancer Res"},{"key":"2151_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11081134","author":"P Cruz-Tapias","year":"2019","unstructured":"Cruz-Tapias P, Zakharova V, Perez-Fernandez OM, Mantilla W, Ram\u00cdRez-Clavijo S, Ait-Si-Ali S. Expression of the major and pro-oncogenic H3K9 lysine methyltransferase SETDB1 in non-small cell lung cancer. Cancers. 2019. https:\/\/doi.org\/10.3390\/cancers11081134.","journal-title":"Cancers"},{"key":"2151_CR16","doi-asserted-by":"publisher","first-page":"139","DOI":"10.5483\/BMBRep.2019.52.2.235","volume":"52","author":"TY Ryu","year":"2019","unstructured":"Ryu TY, Kim K, Kim SK, Oh JH, Min JK, Jung CR, et al. Setdb1 regulates SMAD7 expression for breast cancer metastasis. BMB Rep. 2019;52:139\u201344.","journal-title":"BMB Rep"},{"key":"2151_CR17","first-page":"1803","volume":"11","author":"VJ Lazaro-Camp","year":"2021","unstructured":"Lazaro-Camp VJ, Salari K, Meng X, Yang S. Setdb1 in cancer: overexpression and its therapeutic implications. Am J Cancer Res. 2021;11:1803\u201327.","journal-title":"Am J Cancer Res"},{"key":"2151_CR18","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1093\/jmcb\/mjx055","volume":"10","author":"Q Zheng","year":"2018","unstructured":"Zheng Q, Cao Y, Chen Y, Wang J, Fan Q, Huang X, Wang Y, Wang T, Wang X, Ma J, Cheng J. Senp2 regulates adipose lipid storage by de-SUMOylation of Setdb1. J Mol Cell Biol. 2018;10:258\u201366.","journal-title":"J Mol Cell Biol"},{"key":"2151_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s13072-020-00374-4","volume":"13","author":"T Tsusaka","year":"2020","unstructured":"Tsusaka T, Fukuda K, Shimura C, Kato M, Shinkai Y. The fibronectin type-III (FNIII) domain of ATF7IP contributes to efficient transcriptional silencing mediated by the SETDB1 complex. Epigenetics Chromatin. 2020;13:52.","journal-title":"Epigenetics Chromatin"},{"key":"2151_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00217","volume":"10","author":"X Meng","year":"2020","unstructured":"Meng X, Wang H, Zhao J, Hu L, Zhi J, Wei S, et al. Apatinib inhibits cell proliferation and induces autophagy in human papillary thyroid carcinoma via the PI3K\/Akt\/mTOR signaling pathway. Front Oncol. 2020;10:217.","journal-title":"Front Oncol"},{"key":"2151_CR21","doi-asserted-by":"publisher","DOI":"10.1177\/1010428317694543","volume":"39","author":"J Cheng","year":"2017","unstructured":"Cheng J, Su M, Jin Y, Xi Q, Deng Y, Chen J, et al. Upregulation of SENP3\/SMT3IP1 promotes epithelial ovarian cancer progression and forecasts poor prognosis. Tumor Biol. 2017;39:1010428317694543.","journal-title":"Tumor Biol"},{"key":"2151_CR22","doi-asserted-by":"publisher","first-page":"14958","DOI":"10.1073\/pnas.1921554117","volume":"117","author":"JD Graves","year":"2020","unstructured":"Graves JD, Lee YJ, Liu K, Li G, Lin FT, Lin WC. E2F1 sumoylation as a protective cellular mechanism in oxidative stress response. Proc Natl Acad Sci U S A. 2020;117:14958\u201369.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2151_CR23","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1271\/bbb.100082","volume":"74","author":"N Tanaka","year":"2010","unstructured":"Tanaka N, Saitoh H. A real-time SUMO-binding assay for the analysis of the SUMO-SIM protein interaction network. Biosci Biotechnol Biochem. 2010;74:1302\u20135.","journal-title":"Biosci Biotechnol Biochem"},{"key":"2151_CR24","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1016\/j.molcel.2019.08.026","volume":"75","author":"EM Cornett","year":"2019","unstructured":"Cornett EM, Ferry L, Defossez PA, Rothbart SB. Lysine methylation regulators moonlighting outside the epigenome. Mol Cell. 2019;75:1092\u2013101.","journal-title":"Mol Cell"},{"key":"2151_CR25","first-page":"607","volume":"45","author":"M Ukita","year":"2020","unstructured":"Ukita M, Matsushita K, Tamura M, Yamaguchi T. Histone H3K9 methylation is involved in temporomandibular joint osteoarthritis. Int J Mol Med. 2020;45:607\u201314.","journal-title":"Int J Mol Med"},{"key":"2151_CR26","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1016\/j.bbrc.2020.09.108","volume":"533","author":"J Yamamoto","year":"2020","unstructured":"Yamamoto J, Han Q, Inubushi S, Sugisawa N, Hamada K, Nishino H, Miyake K, Kumamoto T, Matsuyama R, Bouvet M, Endo I, Hoffman RM. Histone methylation status of H3K4me3 and H3K9me3 under methionine restriction is unstable in methionine-addicted cancer cells, but stable in normal cells. Biochem Biophys Res Commun. 2020;533:1034\u20138.","journal-title":"Biochem Biophys Res Commun"},{"key":"2151_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-019-0644-y","volume":"11","author":"J Torrano","year":"2019","unstructured":"Torrano J, Al Emran A, Hammerlindl H, Schaider H. Emerging roles of H3K9me3, SETDB1 and SETDB2 in therapy-induced cellular reprogramming. Clin Epigenetics. 2019;11:43.","journal-title":"Clin Epigenetics"},{"key":"2151_CR28","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/s41419-020-2561-6","volume":"11","author":"N Cao","year":"2020","unstructured":"Cao N, Yu Y, Zhu H, Chen M, Chen P, Zhuo M, Mao Y, Li L, Zhao Q, Wu M, Ye M. SETDB1 promotes the progression of colorectal cancer via epigenetically silencing p21 expression. Cell Death Dis. 2020;11:351.","journal-title":"Cell Death Dis"},{"key":"2151_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2021.109759","volume":"351","author":"Z-F Li","year":"2022","unstructured":"Li Z-F, Meng D-D, Liu Y-Y, Bi F-G, Tian K, Xu J-Z, et al. Hypoxia inducible factor-3\u03b1 promotes osteosarcoma progression by activating KDM3A-mediated demethylation of SOX9. Chem Biol Interact. 2022;351:109759.","journal-title":"Chem Biol Interact"},{"key":"2151_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.00032","volume":"11","author":"Y Liu","year":"2020","unstructured":"Liu Y, Zhang D, Yuan J, Song L, Zhang C, Lin Q, et al. Hyperbaric oxygen ameliorates insulin sensitivity by increasing GLUT4 expression in skeletal muscle and stimulating UCP1 in brown adipose tissue in T2DM mice. Front Endocrinol (Lausanne). 2020;11:32.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2151_CR31","doi-asserted-by":"publisher","first-page":"8","DOI":"10.17305\/bjbms.2018.2756","volume":"18","author":"AM Skoda","year":"2018","unstructured":"Skoda AM, Simovic D, Karin V, Kardum V, Vranic S, Serman L. The role of the Hedgehog signaling pathway in cancer: a comprehensive review. Bosn J Basic Med Sci. 2018;18:8\u201320.","journal-title":"Bosn J Basic Med Sci"},{"key":"2151_CR32","first-page":"100","volume":"57","author":"L Xia","year":"2020","unstructured":"Xia L, Bouamar H, Gu X, Zeballos C, Qin T, Wang B, Zhou Y, Wang Y, Yang J, Zhu H, Zhang W, Houghton PJ, Sun LZ. Gli2 mediates the development of castration\u2013resistant prostate cancer. Int J Oncol. 2020;57:100\u201312.","journal-title":"Int J Oncol"},{"key":"2151_CR33","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1038\/s41374-018-0089-5","volume":"98","author":"H Zhu","year":"2018","unstructured":"Zhu H, Xia L, Shen Q, Zhao M, Gu X, Bouamar H, et al. Differential effects of GLI2 and GLI3 in regulating cervical cancer malignancy in vitro and in vivo. Lab Invest. 2018;98:1384\u201396.","journal-title":"Lab Invest"},{"key":"2151_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-38711-7","volume":"9","author":"H Jiang","year":"2019","unstructured":"Jiang H, Yamashita Y, Nakamura A, Croft K, Ashida H. Quercetin and its metabolite isorhamnetin promote glucose uptake through different signalling pathways in myotubes. Sci Rep. 2019;9:2690.","journal-title":"Sci Rep"},{"key":"2151_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2020.108461","volume":"689","author":"P Bian","year":"2020","unstructured":"Bian P, Hu W, Liu C, Li L. Resveratrol potentiates the anti-tumor effects of rapamycin in papillary thyroid cancer: PI3K\/AKT\/mTOR pathway involved. Arch Biochem Biophys. 2020;689:108461.","journal-title":"Arch Biochem Biophys"},{"key":"2151_CR36","doi-asserted-by":"publisher","first-page":"e2501010","DOI":"10.4014\/jmb.2501.01010","volume":"35","author":"M Liu","year":"2025","unstructured":"Liu M, Zhang L, Yan Z. EIF4A3-induced circ_0092278 enhances papillary thyroid cancer cell malignancy by the PI3K\/Akt\/mTOR signaling pathway. J Microbiol Biotechnol. 2025;35:e2501010.","journal-title":"J Microbiol Biotechnol"},{"key":"2151_CR37","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s40618-022-01928-x","volume":"46","author":"C Shu","year":"2023","unstructured":"Shu C, Wang S, Hu J, Xu M, Deng H, Maimaiti Y, et al. CircNDST1 promotes papillary thyroid cancer progression via its interaction with CSNK2A1 to activate the PI3K-Akt pathway and epithelial-mesenchymal transition. J Endocrinol Invest. 2023;46:545\u201357.","journal-title":"J Endocrinol Invest"},{"key":"2151_CR38","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-21-0352","author":"L Wang","year":"2023","unstructured":"Wang L, Tan H, Huang Y, Guo M, Dong Y, Liu C, et al. TAGLN2 promotes papillary thyroid carcinoma invasion via the Rap1\/PI3K\/AKT axis. Endocr Relat Cancer. 2023. https:\/\/doi.org\/10.1530\/ERC-21-0352.","journal-title":"Endocr Relat Cancer"},{"key":"2151_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/ijms262110498","author":"M Carnazza","year":"2025","unstructured":"Carnazza M, Yang N, Tiwari RK, Geliebter J, Li XM. Natural compounds targeting MAPK, PI3K\/Akt, and JAK\/STAT signaling in papillary thyroid cancer. Int J Mol Sci. 2025. https:\/\/doi.org\/10.3390\/ijms262110498.","journal-title":"Int J Mol Sci"},{"key":"2151_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1551271","volume":"16","author":"X Xue","year":"2025","unstructured":"Xue X, Wu D, Yao H, Wang K, Liu Z, Qu H. Mechanisms underlying the promotion of papillary thyroid carcinoma occurrence and progression by Hashimoto\u2019s thyroiditis. Front Endocrinol (Lausanne). 2025;16:1551271.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2151_CR41","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.canlet.2015.11.006","volume":"370","author":"J Zhou","year":"2016","unstructured":"Zhou J, Zhu G, Huang J, Li L, Du Y, Gao Y, et al. Non-canonical GLI1\/2 activation by PI3K\/AKT signaling in renal cell carcinoma: a novel potential therapeutic target. Cancer Lett. 2016;370:313\u201323.","journal-title":"Cancer Lett"},{"key":"2151_CR42","doi-asserted-by":"publisher","first-page":"556","DOI":"10.3389\/fgene.2019.00556","volume":"10","author":"S Pietrobono","year":"2019","unstructured":"Pietrobono S, Gagliardi S, Stecca B. Non-canonical Hedgehog Signaling Pathway in Cancer: Activation of GLI Transcription Factors Beyond Smoothened. Front Genet. 2019;10:556.","journal-title":"Front Genet"},{"key":"2151_CR43","doi-asserted-by":"crossref","unstructured":"Zhang S, Xiao J, Chai Y, Hong Z, Liu Z, Yuan R, et al. Speckle-type POZ protein down-regulates matrix metalloproteinase 2 expression via Sp1\/PI3K\/Akt signaling pathway in colorectal cancer. Dig Dis Sci. 2018;63:395\u2013402.","DOI":"10.1007\/s10620-017-4884-4"},{"key":"2151_CR44","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s13238-015-0216-7","volume":"7","author":"M Wang","year":"2016","unstructured":"Wang M, Sang J, Ren Y, Liu K, Liu X, Zhang J, Wang H, Wang J, Orian A, Yang J, Yi J. SENP3 regulates the global protein turnover and the Sp1 level via antagonizing SUMO2\/3-targeted ubiquitination and degradation. Protein Cell. 2016;7:63\u201377.","journal-title":"Protein Cell"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-026-02151-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-026-02151-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-026-02151-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T23:03:08Z","timestamp":1782082988000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-026-02151-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,23]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2151"],"URL":"https:\/\/doi.org\/10.1007\/s10238-026-02151-1","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,23]]},"assertion":[{"value":"19 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Declarations"}},{"value":"This study was approved by the Medical Ethics Committee of the Second Affiliated Hospital of Medical College, Xi\u2019an JiaoTong University (Approval number: XJTULAC-2024021). All patients had read and signed the informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent for publication was obtained from each author","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"237"}}